Preventive Use of Ivermectin Reduced COVID-19 Mortality by 90% | G3 News

Preventive Use of Ivermectin Reduced COVID-19 Mortality by 90% Among More Than 223,000 Study Participants

@COVID19Up: A peer-reviewed study published last month in the Cureus Journal of Medical Science found the prophylactic use of ivermectin reduced COVID-19 mortality by 90% among more than 223,000 study participants in a town in Southern Brazil.

Based on the results, Dr. Flavio Cadegiani, one of the study’s lead authors, said, “Ivermectin must be considered as an option, particularly during outbreaks.”

Dr. Pierre Kory told The Epoch Times the results of the study “should convince any naysayer. What they found was astounding.”

“You would think this would lead to major headlines everywhere. And yet, nothing. And this is not new, this censorship of this highly effective science and evidence around repurposed drugs. The censoring of it, it’s not new, it’s just getting more and more absurd. And it has to stop," Kory said.

Kory added that it’s not even about ivermectin, “it’s about the pharmaceutical industry’s capture of our agencies and how our policies are all directed at suppressing and avoiding use of re-purposed drugs” in favor of high-profit medicines.

Talk about it:
@COVID1984Chat

Follow us:
@COVID19Up